MyDrHank Review: Among the Cheapest ED Pricing We've Found — On a Site That Publishes No Refund Policy At All

What Is MyDrHank?

MyDrHank trades as Dr. Hank, LLC and its Terms of Use are governed by Tennessee law, with disputes resolved by binding arbitration in Nashville under American Arbitration Association rules. The BBB lists it at 300 20th Ave N #105, Nashville, with a file opened on 16 September 2021. It is not BBB accredited and carries no rating at all — the BBB states it 'does not have sufficient information to issue a rating', which is different from a bad rating but also means there is no independent complaint record to consult.

The catalogue spans five categories: sexual health (generic sildenafil, generic tadalafil, daily tadalafil and a compounded sildenafil-plus-tadalafil rapid-dissolve tablet branded MDH Drive), weight loss (compounded semaglutide, compounded tirzepatide and oral semaglutide), longevity (NAD+ nasal spray and injection, glutathione nasal spray and injection), hair (oral minoxidil, oral finasteride and a five-formulation compounded Custom Hair Protocol) and a sermorelin peptide protocol.

Pricing is the strongest thing here. Generic sildenafil from $25 a month and tadalafil from $30 undercut most of the branded telehealth field, consultations and shipping are free, and the GLP-1 entry point of $171 is competitive. MyDrHank states there is 'no membership or hidden fees' — and unlike several competitors in this series, we found no evidence of a separate membership charge layered on top of medication.

The disclosure is a genuinely mixed picture, and it is the reason this review lands where it does. On regulatory status MyDrHank is careful and correct: compounded products carry the disclaimer that they 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality', the MDH Drive page adds that the product 'is not equivalent to any FDA-approved drug', and the GLP-1 page notes that trial data reflects FDA-approved formulations rather than compounded versions. That is more precise than most of this market manages. On evidence and on commercial policy, it is considerably weaker.

Every Product and What It Costs

All prices checked on mydrhank.com on 7 August 2026, and every one is a 'from' price — MyDrHank states that 'final pricing depends on the medication, dose, and treatment plan prescribed', so your actual cost is set after the consultation. Two figures did not agree with themselves on the day we checked: the homepage listed compounded semaglutide from $178 and tirzepatide from $240, while the GLP-1 landing page listed $171 and $200 for the same products. That is a $40 discrepancy on tirzepatide between two pages of the same site on the same day. Get your price confirmed before you pay. Note also that prices appear on individual product pages but not on the category pages, so browsing by category tells you nothing about cost.

What's FDA-Approved Here and What Isn't

Roughly half the catalogue is compounded: MDH Drive, the Custom Hair Protocol, both NAD+ products, both glutathione products, sermorelin, and all three GLP-1s. Generic sildenafil, generic tadalafil, daily tadalafil and finasteride are conventional FDA-approved generics.

MyDrHank handles this well. Compounded product pages carry the disclaimer that these drugs 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality', the MDH Drive page states plainly that the product 'is not equivalent to any FDA-approved drug', and the Custom Hair Protocol page specifies that compounded medications are 'not FDA-approved as combination products'. The GLP-1 page adds the caveat that matters most: trial data reflects the FDA-approved formulations, not the compounded versions being sold. Several providers in this series never make that distinction at all.

One inconsistency is worth naming, because it is aimed at partners rather than patients. The material MyDrHank supplies to affiliates describes its service as offering 'FDA-approved medications'. Its consumer pages correctly say the opposite about the compounded half of the catalogue. Patients see the accurate version; we are noting the discrepancy because we saw both.

Oral minoxidil is the one place the consumer-facing disclosure slips. The page refers to an 'FDA-approved active ingredient', which is true of topical minoxidil — the oral tablet is not approved for hair loss and is prescribed off-label. Off-label prescribing is legal and, for oral minoxidil in hair loss, increasingly common and supported by published evidence. But it is off-label, MyDrHank does not say so, and low-dose oral minoxidil carries cardiovascular considerations — fluid retention, ankle swelling, tachycardia, pericardial effusion in rare cases — that make the distinction worth knowing.

NAD+ deserves particular care. FDA has publicly reminded compounders that it is aware of them using food-grade NAD+ sold by repackagers to make injectable products, warning that ingredients identified as food grade 'are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins'. That is an industry-wide warning, not a finding about MyDrHank specifically, and MyDrHank states its NAD+ is prepared by a state-licensed US compounding pharmacy. But since it does not name that pharmacy, ask which one, and ask whether the NAD+ is pharmaceutical grade.

The Consultation Process

Eligibility

• •Adults 18 and over, in the United States only, with a prescription required after evaluation by a US-licensed clinician. MyDrHank states its products are 'available in select U.S. states' without publishing the list — ask before you start. Separately, this offer is not available to residents of Kansas, Louisiana, Mississippi, New Mexico, North Dakota or West Virginia.
• •MyDrHank excludes anyone with active malignancy, anyone pregnant or nursing, and anyone under 18 from its sermorelin and NAD+ protocols.
• •PDE5 inhibitors — sildenafil, tadalafil and the compounded combination in MDH Drive — must never be taken with nitrates in any form. The combination can cause a severe and potentially fatal drop in blood pressure. Use caution with alpha-blockers, and avoid if a clinician has advised against sexual activity on cardiovascular grounds.
• •Seek immediate medical care for an erection lasting more than four hours, sudden vision loss, or sudden hearing loss or ringing in the ears.
• •MDH Drive combines two PDE5 inhibitors in one compounded tablet. That is not a combination available as an FDA-approved product, and taking two agents from the same class together means their blood-pressure-lowering effects add. Discuss it specifically with the prescriber, particularly if you take any antihypertensive.
• •Finasteride must not be used by women who are or may become pregnant, and broken tablets should not be handled by them — it can cause abnormalities in a male foetus. It can also cause sexual side effects that some men report as persistent after stopping, and it suppresses PSA, so tell any clinician measuring your PSA that you take it.
• •Oral minoxidil can cause fluid retention, ankle swelling, increased heart rate, unwanted body hair and, rarely, pericardial effusion. Anyone with heart disease should discuss it carefully.
• •GLP-1 medicines are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in pregnancy — MyDrHank publishes this correctly. Common side effects are gastrointestinal; less common but serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury.
• •Unlike the strongest providers in this series, MyDrHank's product pages do not display side-effect detail inline — the finasteride page, for example, carries a 'What are the side effects?' heading that sits behind a toggle rather than presenting the information directly. Ask the clinician, and read the material that ships with the medication.

Clinicians, Labs & Pharmacy

Shipping & Support Services

Free, discreet, unmarked packaging, shipped within the contiguous US. No delivery timeframe is published.

• •Free consultation with no charge if you are declined
• •Free shipping on every product
• •No membership fee stacked on top of medication
• •Correct and prominent compounded-drug disclaimers
• •States plainly that GLP-1 trial data reflects approved formulations, not compounded ones
• •Discloses on the glutathione page that its cited study examined a different compound
• •Acknowledges that clinical evidence for nasal and injectable NAD+ is limited
• •Physician review of most assessments within 24 hours
• •LegitScript seal displayed on the site
• •Both men's and women's hair options

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who MyDrHank May Be Best For

• •Price-driven buyers who want generic sildenafil or tadalafil cheaply and will cancel manually when done
• •People who want ED, hair and weight-loss prescriptions from one provider without a membership fee
• •Anyone who values a company that prints the compounded-drug disclaimer properly instead of blurring it
• •Buyers comfortable asking direct questions about refunds and cancellation before their first order

Limitations

• •The missing refund policy is the central problem, and it is not a technicality. Every landing page promises 'cancel anytime', the entire model is recurring monthly billing, and the Terms of Use — the only document that actually binds either party — say nothing about cancellation, auto-renewal or refunds. That combination means that if a shipment goes missing or a charge lands after you cancel, there is no published term to point to. Get the answers in writing before you order.
• •The evidence handling follows a consistent and slightly odd pattern: cite a real study, then quietly disclose that it studied something else. The NAD+ pages headline '6x increase in whole blood NAD+ after 12 weeks' and cite Igarashi et al., npj Aging 2022 — a paper whose full title MyDrHank prints, and which examined chronic oral nicotinamide mononucleotide supplementation at 250 mg a day in healthy older men. NMN is a different molecule from NAD+, taken by mouth rather than injected or sprayed into the nose, and the abstract does not report a six-fold figure at all. The same pages then admit that 'clinical evidence for nasal and injectable NAD+ delivery is limited'. The glutathione page repeats the structure and is even more explicit, noting that the Sekhar trial it cites 'studied GlyNAC (glycine + N-acetylcysteine) supplementation, not direct glutathione administration'. Crediting the honesty of those admissions is fair. So is pointing out that the headline number and the disclaimer contradict each other, and that the number is what a buyer will remember.
• •The GLP-1 efficacy figures have the same problem. MyDrHank shows 8.3% average weight loss for semaglutide and 14.9% for tirzepatide, with no source given. The landmark trials do not read that way: STEP 1 (Wilding et al., NEJM 2021) reported a mean weight change of −14.9% with semaglutide 2.4 mg at 68 weeks, and SURMOUNT-1 (Jastreboff et al., NEJM 2022) reported −20.9% with tirzepatide 15 mg at 72 weeks. The 14.9% attached to tirzepatide is the semaglutide headline number. To MyDrHank's credit, it does state that trial data reflects FDA-approved formulations rather than the compounded products it sells — which is the caveat that matters most, and one many competitors omit.
• •Two smaller things compound the impression of a site assembled quickly. The homepage and the GLP-1 landing page quoted different prices for the same two products on the same day, a $40 gap on tirzepatide. And the browser tab reads 'MyDrHank Telehealth Plaform'. Neither is dangerous. Both suggest the pages were not checked closely, which is exactly the concern when the substantive claims are also loosely sourced.
• •Set against all of that, the prices are real and the regulatory disclosure is genuinely better than average. Sildenafil at $25 a month is competitive with anyone. Stating that compounded MDH Drive 'is not equivalent to any FDA-approved drug' is precisely the sentence patients need and rarely get. And the BBB's 'Not Rated' is an absence of information rather than a record of complaints — this is a small operation with a thin public footprint, not one with a documented history of harming customers.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

MyDrHank is cheap, and the cheapness is real rather than a teaser. Generic sildenafil at $25 a month and tadalafil at $30 undercut most of the branded telehealth field, the consultation is free with no charge if you are declined, shipping is free, and there is no membership fee sitting on top of the medication. For someone who wants a generic ED prescription at the lowest published price, that is a straightforward proposition.

Its regulatory disclosure is also better than the market average. Compounded products carry the correct disclaimer, MDH Drive's page states outright that it 'is not equivalent to any FDA-approved drug', and the GLP-1 page concedes that trial data reflects approved formulations rather than compounded ones. Several providers we have reviewed never make that distinction at all.

The evidence handling is where it comes apart, and it does so in a consistent way: cite a real paper, headline a big number, then admit in smaller type that the paper studied something else. The NAD+ pages advertise a six-fold rise in blood NAD+ citing a trial of oral NMN in older men — a different molecule, a different route, and no six-fold figure in the abstract — while conceding on the same page that evidence for nasal and injectable NAD+ is limited. The glutathione page cites a trial of GlyNAC and says so. The GLP-1 percentages match neither STEP 1 nor SURMOUNT-1 and carry no source. The disclaimers are honest; the headlines they sit beneath are not.

And then there is the gap that would matter most if something went wrong. There is no refund policy published anywhere on this site, and the Terms of Use contain no cancellation or auto-renewal provision at all, despite 'cancel anytime' appearing on every landing page. For a business built entirely on recurring monthly charges, that is the one disclosure that should not be missing. The BBB's 'Not Rated' means there is no independent complaint record to fall back on either.

We rate MyDrHank 3.5 out of 5 — real prices and honest regulatory language, undercut by promotional claims its own fine print contradicts and by commercial terms it has not published.

Buy it if you want a low-cost generic ED or hair prescription and you are the kind of buyer who will email support for the refund policy before ordering and cancel deliberately when finished. Look elsewhere for the longevity products, where you would be paying $103 to $155 a month for compounded treatments the company itself says lack good clinical evidence. And if it is GLP-1 weight loss you are after, cheaper and better-documented options exist.

This review is informational only and is not medical advice. Compounded medications — including MDH Drive, the Custom Hair Protocol, NAD+, glutathione, sermorelin and compounded GLP-1s — are not FDA-approved. Speak to a licensed clinician about whether any treatment is appropriate for you before starting, changing or stopping medication.